Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2

Yvonne C. F. Su,Danielle E. Anderson,Barnaby E. Young,Martin Linster,Feng Zhu,Jayanthi Jayakumar,Yan Zhuang,Shirin Kalimuddin,Jenny G. H. Low,Chee Wah Tan,Wan Ni Chia,Tze Minn Mak,Sophie Octavia,Jean-Marc Chavatte,Raphael T. C. Lee,Surinder Pada,Seow Yen Tan,Louisa Sun,Gabriel Z. Yan,Sebastian Maurer-Stroh,Ian H. Mendenhall,Yee-Sin Leo,David Chien Lye,Lin-Fa Wang,Gavin J. D. Smith
DOI: https://doi.org/10.1128/mbio.01610-20
IF: 6.4
2020-08-25
mBio
Abstract:During the SARS epidemic in 2003/2004, a number of deletions were observed in ORF8 of SARS-CoV, and eventually deletion variants became predominant, leading to the hypothesis that ORF8 was an evolutionary hot spot for adaptation of SARS-CoV to humans. However, due to the successful control of the SARS epidemic, the importance of these deletions for the epidemiological fitness of SARS-CoV in humans could not be established. The emergence of multiple SARS-CoV-2 strains with ORF8 deletions, combined with evidence of a robust immune response to ORF8, suggests that the lack of ORF8 may assist with host immune evasion. In addition to providing a key insight into the evolutionary behavior of SARS-CoV-2 as the virus adapts to its new human hosts, the emergence of ORF8 deletion variants may also impact vaccination strategies.
microbiology
What problem does this paper attempt to address?